Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)LIVERMORE, David M; MUSHTAQ, Shazad; BARKER, Kevin et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 6, pp 1354-1358, issn 0305-7453, 5 p.Article

Cinétique de l'activité sérique des inhibiteurs de bêta-lactamases : mise au point d'une méthode biologique = Kinetics of serum activity of beta-lactamases inhibitors. Development of a biologic assaySOTTO, A; CARRIERE, C; CARLES, M. J et al.Pathologie et biologie. 1991, Vol 39, Num 2, pp 147-149, issn 0369-8114Article

Role of Asp104 in the SHV β-lactamaseBETHEL, Christopher R; HUJER, Andrea M; HUJER, Kristine M et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 12, pp 4124-4131, issn 0066-4804, 8 p.Article

Automated analysis of enzyme inactivation phenomena: application to β-lactamases and DD-peptidasesDE MEESTER, F; JORIS, B; RECKINGER, G et al.Biochemical pharmacology. 1987, Vol 36, Num 14, pp 2393-2403, issn 0006-2952Article

β-Lactamase nomenclatureJACOBY, George A.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1123-1129, issn 0066-4804, 7 p.Article

The new β-lactamasesJACOBY, George A; MUNOZ-PRICE, Luisa Silvia.The New England journal of medicine. 2005, Vol 352, Num 4, pp 380-391, issn 0028-4793, 12 p.Article

Updated Functional Classification of β-LactamasesBUSH, Karen; JACOBY, George A.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 3, pp 969-976, issn 0066-4804, 8 p.Article

CMY-31 and CMY-36 Cephalosporinases Encoded by ColEl-Like PlasmidsZIOGA, A; WHICHARD, J. M; KOTSAKIS, S. D et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 3, pp 1256-1259, issn 0066-4804, 4 p.Article

Inhibition of OXA-1 β-Lactamase by PenemsBETHEL, Christopher R; DISTLER, Anne M; ANDERSON, Vernon E et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 9, pp 3135-3143, issn 0066-4804, 9 p.Article

The CTX-M β-lactamase pandemicCANTON, Rafael; COQUE, Teresa M.Current opinion in microbiology. 2006, Vol 9, Num 5, pp 466-475, issn 1369-5274, 10 p.Article

TLA-2, a novel ambler class A expanded-spectrum β-lactamaseGIRLICH, Delphine; POIREL, Laurent; SEHLFITER, Andreas et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4767-4770, issn 0066-4804, 4 p.Article

Biochemical characterization of the THIN-B metallo-β-lactamase of Janthinobacterium lividumDOCQUIER, Jean-Denis; LOPIZZO, Teresa; LIBERATORI, Sabrina et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4778-4783, issn 0066-4804, 6 p.Article

Definitive nomenclature of GES/IBC-type extended-spectrum β-lactamasesWELDHAGEN, Gerhard F; KIM, Bokhee; CHO, Chan-Hwi et al.Journal of microbiology and biotechnology. 2006, Vol 16, Num 11, pp 1837-1840, issn 1017-7825, 4 p.Article

Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamasesCOLINON, Céline; MIRIAGOU, Vivi; CARATTOLI, Alessandra et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 2, pp 258-262, issn 0305-7453, 5 p.Article

Multilocus sequence typing of IncN plasmidsGARCIA-FERNANDEZ, Aurora; VILLA, Laura; MOODLEY, Arshnee et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 1987-1991, issn 0305-7453, 5 p.Article

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with CeftolozaneVANSCOY, Brian; MENDES, Rodrigo E; AMBROSE, Paul G et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5924-5930, issn 0066-4804, 7 p.Article

Detection of bacterial strains producing sulbactam or tazobactam-sensitive β-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibioticsBANIC, S.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2006, Vol 114, Num 1, pp 3-9, issn 0903-4641, 7 p.Article

Traitement des infections à entérobactéries productrices de BLSE: alternatives aux carbapénèmes = Treatment of infections due to ESBL-producing Enterobacteriaceae: alternatives to carbapenemsHENARD, S; AISSA, N; LOZNIEWSKI, A et al.La Lettre de l'infectiologue. 2014, Vol 29, Num 4, pp 140-144, issn 0296-9009, 5 p.Article

CTX-M : changing the face of ESBLs in EuropeLIVER-MORE, David M; CANTON, Rafael; POIREL, Laurent et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 2, pp 165-174, issn 0305-7453, 10 p.Article

β-lactamase reporter system for selecting high-producing yeast clonesHRIBAR, Gorazd; SMILOVIC, Vanja; ANA LENASSI ZUPAN et al.BioTechniques. 2008, Vol 44, Num 4, issn 0736-6205, 477-484 [5 p.]Article

Interactions of ceftobiprole with β-lactamases from molecular classes A to DQUEENAN, Anne Marie; WENCHI SHANG; KANIA, Malgosia et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 9, pp 3089-3095, issn 0066-4804, 7 p.Article

Structure-based phylogeny of the metallo-β-lactamasesGARAU, Gianpiero; DI GUILMI, Anne Marie; HALL, Barry G et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 7, pp 2778-2784, issn 0066-4804, 7 p.Article

AmpC β-lactamases: what do we need to know for the future?HANSON, Nancy D.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 1, pp 2-4, issn 0305-7453, 3 p.Article

Hydrolysis of β-lactamase-stable β-lactams by type I sponge β-lactamasesWHITE, A. J; CURTIS, N. A. C.Journal of antimicrobial chemotherapy (Print). 1985, Vol 16, Num 3, pp 403-405, issn 0305-7453Article

Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-LactamasePAPP-WALLACE, Krisztina M; BETHEL, Christopher R; DISTLER, Anne M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 890-897, issn 0066-4804, 8 p.Article